How FIRST40 and DOSE25 Codes Work for Both Treatments
Mounjaro vs Wegovy UK Discount Code Savings Breakdown
When comparing Mounjaro vs Wegovy UK pricing, discount codes FIRST40 (new customers) and DOSE25 (returning customers) apply to both treatments at checkout. The codes are designed to make either option more accessible whilst maintaining the same clinical assessment standards. Wegovy pricing starts at £79.99 for the 0.25mg starter dose after applying FIRST40, with clear escalation pricing through to the 2.4mg maintenance dose at £209.99. Both medications require the same prescription-only medicine protocols and clinical oversight.
The discount codes work identically for Mounjaro vs Wegovy UK orders, ensuring fair comparison between the two treatments. FIRST40 provides substantial savings for those beginning their weight management journey, whilst DOSE25 supports ongoing treatment adherence. The codes are applied automatically at checkout, with no minimum order requirements or complex terms. This transparent pricing structure helps patients focus on the clinical differences between semaglutide and tirzepatide rather than navigating pricing complications.
Mounjaro vs Wegovy UK Bundle Pricing with Discount Codes Applied
Bundle options for Mounjaro vs Wegovy UK provide convenient multi-month supplies with discount codes pre-applied to the listed prices. The Intro Duo (0.25mg & 0.5mg Wegovy) costs £169.99 with codes applied, covering the first 8 weeks of treatment. Progress Duo (0.5mg & 1mg) at £189.99 supports weeks 5-12, whilst the Advance Duo (1mg & 1.7mg) at £269.99 covers the transition to higher doses. These bundles eliminate the need for multiple orders during dose escalation phases.
Three-pen bundles offer extended supply options for Mounjaro vs Wegovy UK patients committed to longer treatment periods. The Intro Trio (0.25mg, 0.5mg & 1mg) provides 12 weeks of progressive dosing for £299.99, whilst the Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99. Bundle pricing includes the convenience factor of fewer deliveries, Reliable Supply continuity, and simplified prescription management. Both FIRST40 and DOSE25 codes work with all bundle configurations.
Clinical Evidence Supporting Mounjaro vs Wegovy UK Treatment Decisions
The STEP clinical trial programme demonstrated Wegovy's efficacy in weight management, with STEP 1 showing participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 specifically evaluated patients with type 2 diabetes, showing 9.6% average weight loss. These trials established semaglutide's role as a GLP-1 receptor agonist for weight management when used alongside reduced-calorie diet and increased physical activity.
Mounjaro's tirzepatide mechanism involves dual GIP and GLP-1 receptor activation, representing a different pharmacological approach compared to Wegovy's GLP-1-only targeting. When considering Mounjaro vs Wegovy UK options, both treatments require similar clinical monitoring and lifestyle interventions. The choice between these prescription-only medicines depends on individual patient factors, medical history, and prescriber assessment rather than clinical trial comparisons across different study designs and populations.
How Wegovy Works: GLP-1 Mechanism for Mounjaro vs Wegovy UK Comparison
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones in the body. This mechanism helps reduce appetite by acting on brain centres that control hunger and satiety, promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, contributing to prolonged satiety and reduced food cravings. When comparing Mounjaro vs Wegovy UK mechanisms, this single-target approach differs from tirzepatide's dual-receptor activation. The once-weekly injection schedule supports treatment adherence compared to daily medications, with the FlexTouch pen system designed for patient convenience.
Ordering Process for Mounjaro vs Wegovy UK with Discount Codes
The ordering process for both Mounjaro vs Wegovy UK treatments begins with a 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review all applications within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for either treatment option. Once approved, medications are dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain product integrity. The discount codes FIRST40 or DOSE25 are applied at checkout, with the listed prices reflecting the final cost after code application. Our GPhC #9012878 registered pharmacy handles all dispensing with full regulatory compliance.
Storage and Practical Considerations: Mounjaro vs Wegovy UK Differences
Storage requirements differ between Mounjaro vs Wegovy UK options, with Wegovy offering superior temperature flexibility for travel and lifestyle convenience. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use and utilise pre-filled pen injection systems. The dose escalation schedule for Wegovy follows a structured 4-week progression from 0.25mg to maintenance 2.4mg dosing. This practical advantage makes Wegovy suitable for patients with frequent travel schedules or limited refrigeration access during holidays.
Mounjaro vs Wegovy UK: Making Treatment Decisions with Discount Code Access
Access to both Mounjaro vs Wegovy UK treatments through EverydayMeds ensures patients receive unbiased clinical assessment rather than treatment preference based on pricing structures. The identical discount code system (FIRST40 for new patients, DOSE25 for returning patients) eliminates cost as the primary decision factor. This approach supports evidence-based prescribing where treatment selection focuses on medical suitability, contraindications, and individual patient factors rather than financial considerations.
The availability of transparent bundle pricing for both Mounjaro vs Wegovy UK options supports long-term treatment planning and budgeting. Patients can discuss treatment duration, expected dose progression, and maintenance phase planning with prescribers without pricing uncertainties affecting clinical decisions. Both treatments require ongoing lifestyle modification support, including reduced-calorie diet and increased physical activity, with similar monitoring requirements for side effects and treatment response evaluation.
Complete Your Mounjaro vs Wegovy UK Assessment with Confirmed Savings
Beginning your weight management journey with either Mounjaro or Wegovy through EverydayMeds ensures access to discount pricing through our established code system. The FIRST40 code provides immediate savings for new patients, whilst DOSE25 ensures continued value for ongoing treatment phases. Our clinical team provides equal expertise in both semaglutide and tirzepatide prescribing, with treatment selection based purely on medical appropriateness and patient preference. Complete your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to access both treatment options with transparent pricing and expert clinical oversight. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
